341 related articles for article (PubMed ID: 19064314)
21. Transient receptor potential vanilloid 1 channels modulate the anxiolytic effect of diazepam.
Manna SS; Umathe SN
Brain Res; 2011 Nov; 1425():75-82. PubMed ID: 22018687
[TBL] [Abstract][Full Text] [Related]
22. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
Casarotto PC; Terzian AL; Aguiar DC; Zangrossi H; Guimarães FS; Wotjak CT; Moreira FA
Neuropsychopharmacology; 2012 Jan; 37(2):478-86. PubMed ID: 21937980
[TBL] [Abstract][Full Text] [Related]
23. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
Moreira FA; Aguiar DC; Guimarães FS
Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
[TBL] [Abstract][Full Text] [Related]
24. Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation.
Back FP; Carobrez AP
Neuropharmacology; 2018 Jun; 135():399-411. PubMed ID: 29596901
[TBL] [Abstract][Full Text] [Related]
25. Genotype-dependent responsivity to inflammatory pain: A role for TRPV1 in the periaqueductal grey.
Madasu MK; Okine BN; Olango WM; Rea K; Lenihan R; Roche M; Finn DP
Pharmacol Res; 2016 Nov; 113(Pt A):44-54. PubMed ID: 27520401
[TBL] [Abstract][Full Text] [Related]
26. Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory.
Li HB; Mao RR; Zhang JC; Yang Y; Cao J; Xu L
Biol Psychiatry; 2008 Aug; 64(4):286-92. PubMed ID: 18405883
[TBL] [Abstract][Full Text] [Related]
27. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
Lisboa SF; Resstel LB; Aguiar DC; Guimarães FS
Eur J Pharmacol; 2008 Sep; 593(1-3):73-8. PubMed ID: 18691568
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
[TBL] [Abstract][Full Text] [Related]
29. TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist.
Gevaert T; Vandepitte J; Hutchings G; Vriens J; Nilius B; De Ridder D
Neurourol Urodyn; 2007; 26(3):440-50; discussion 451-3. PubMed ID: 17266134
[TBL] [Abstract][Full Text] [Related]
30. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
Miguel TT; Nunes-de-Souza RL
Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
[TBL] [Abstract][Full Text] [Related]
31. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
[TBL] [Abstract][Full Text] [Related]
32. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC
Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073
[TBL] [Abstract][Full Text] [Related]
33. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
Bertoglio LJ; Zangrossi H
Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
[TBL] [Abstract][Full Text] [Related]
34. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
[TBL] [Abstract][Full Text] [Related]
35. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
Wall PM; Messier C
Psychopharmacology (Berl); 2002 Mar; 160(3):233-44. PubMed ID: 11889492
[TBL] [Abstract][Full Text] [Related]
36. Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviors.
Kasckow JW; Mulchahey JJ; Geracioti TD
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):291-5. PubMed ID: 14751425
[TBL] [Abstract][Full Text] [Related]
37. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
38. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
John CS; Currie PJ
Behav Brain Res; 2012 Aug; 233(2):382-8. PubMed ID: 22633963
[TBL] [Abstract][Full Text] [Related]
39. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
40. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]